Analysis of data gaps pertaining to Shigella infect

细菌耐药

Epidemiol Infect. 2008 May;136(5):577-603. Epub 2007 Aug 9.
Part II. Analysis of data gaps pertaining to Shigella infections in low and medium human development index countries, 1984-2005.
Ram PK, Crump JA, Gupta SK, Miller MA, Mintz ED.

SourceDepartment of Social and Preventive Medicine, School of Public Health and Health Professions, University at Buffalo, Buffalo, NY 14214, USA. pkram@buffalo.edu

AbstractThe global incidence of Shigella infection has been estimated at 80-165 million episodes annually, with 99% of episodes occurring in the developing world. To identify contemporary gaps in the understanding of the global epidemiology of shigellosis, we conducted a review of the English-language scientific literature from 1984 to 2005, restricting the search to low and medium human development countries. Our review yielded 11 population-based studies of Shigella burden from seven countries. No population-based studies have been conducted in sub-Saharan Africa or in low human development countries. In studies done in all age groups, Shigella incidence varied from 0.6 to 107 episodes/1000 person-years. S. flexneri was the most commonly detected subgroup in the majority of studies. Case-fatality rates ranged from 0% to 2.6% in population-based studies and from 0% to 21% in facility-based studies. This review highlights the large gaps in data on the burden of Shigella infections for low human development index countries and, more specifically, for sub-Saharan Africa.

细菌耐药

Fig. 1
Incidence of shigellosis, by geographic region, 1984–2005. Countries contributing incidence data: China, Thailand, Egypt, Bangladesh and Brazil.

细菌耐药

Here the whole version of this paper.